US Stock MarketDetailed Quotes

ADXN Addex Therapeutics

Watchlist
  • 8.1100
  • +0.7300+9.89%
Close Nov 21 16:00 ET
  • 8.2000
  • +0.0900+1.11%
Post 20:01 ET
8.67MMarket Cap0.00P/E (TTM)

Addex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Addex Therapeutics Q3 2024 Estimates Date

Currency：CHFNov 22, 2024

Estimate YoY
Revenue
110.00K
-66.57%
Analyst Rating
Buy

Sep 30, 2024

Addex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CHF

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 150.000K--
Nov 22, 20242024/Q3-- / 110.000K--
Sep 30, 20242024/Q2115.280K / 221.000K--
Jun 6, 20242024/Q1-- / 235.000K--
--2023/Q4153.450K / 651.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 150.000K--
Nov 22, 20242024/Q3-- / 110.000K--
Sep 30, 20242024/Q2115.280K / 221.000K--
Jun 6, 20242024/Q1-- / 235.000K--
--2023/Q4153.450K / 651.000K--

Unlock Free Earnings Estimates

Addex Therapeutics Earnings Reports

  • Addex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 12 11:41 ET

  • Addex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 30 06:04 ET

  • Addex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 19 06:10 ET

  • Addex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 6 06:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data